ACRX Forecast and Technical Stock Analysis
Sell candidate since 2019-09-20 PDF
AcelRx Pharmaceuticals fell by -0.79% in the last day ( Friday, 20th Sep 2019 ) from $2.52 to $2.50 and has now fallen 3 days in a row. During the day the stock fluctuated 4.40% from a day low at $2.50 to a day high of $2.61. The price has risen in 6 of the last 10 days and is up by 6.38% over the past 2 weeks. Volume has increased in the last day by 407 720 shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 930 947 shares bought and sold for approximately $2.33 million.
- 30 day high of the ACRX stock price was $2.80 and low was $2.06.
- 90 day high was $3.02 and low was $2.02.
- 52 week high for AcelRx Pharmaceuticals - $5.05 and low - $1.99.
AcelRx Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -5.59% during the next 3 months and, with 90% probability hold a price between $1.84 and $2.59 at the end of this period.
There are mixed signals in the stock today. A sales signal was issued from a pivot top point on Monday September 16, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. AcelRx Pharmaceuticals holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $2.57. On a fall, the stock will find some support from the long-term average at approximately $2.35. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 59 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
AcelRx Pharmaceuticals finds support from accumulated volume at $2.42.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.11 between high and low, or 4.40%. For the last week, the stock has had a daily average volatility of 7.38%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
7.38 %Average volatility
Very Low Low Medium High Very High
AcelRx Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.
|ACRX $2.50 ($-0.02 -0.79%)|
ACRX is down $0.02 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACRX based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ACRX analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!